Antiphospholipid-negative Sneddon's syndrome: A comprehensive overview of a rare entity.
Antiphospholipid
Cerebral infarction
Livedo racemosa
Sneddon's syndrome
Journal
Annales de dermatologie et de venereologie
ISSN: 0151-9638
Titre abrégé: Ann Dermatol Venereol
Pays: France
ID NLM: 7702013
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
05
01
2021
revised:
26
05
2021
accepted:
04
08
2021
pubmed:
7
11
2021
medline:
23
2
2022
entrez:
6
11
2021
Statut:
ppublish
Résumé
The term Sneddon's syndrome (SS) has been used since 1965 to describe a vasculopathy characterized by a combination of cerebrovascular disease with livedo racemosa. SS may be classified as antiphospholipid+ (aPL+) or antiphospholipid- (aPL-). Little is known about aPL- SS; in this review we describe the epidemiology and pathogenesis of aPL- SS, as well as the clinical and histologic features. We discuss recent findings in terms of neurologic and cardiac involvement. Moreover, differential diagnoses of conditions that may present with both livedo racemosa and stroke are discussed. Finally, we discuss real-life practical issues such as the initial investigations to be performed, long-term follow-up, and therapeutic management of aPL- SS patients.
Identifiants
pubmed: 34740467
pii: S0151-9638(21)00096-X
doi: 10.1016/j.annder.2021.08.007
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3-13Informations de copyright
Copyright © 2021 Elsevier Masson SAS. All rights reserved.